Skip to main content

Winton Group Ltd

SEC CIK
0001612063
Latest filing
Aug 7, 2026

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings

Shares (Q2 2026)
43,200
Value
$103.7K
% of portfolio
<0.1%
Quarters held
6
Since Q1 2021
Holdings of LXRX by Winton Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202643,200$103.7K<0.1%+17,700+69.4%AddedHolders
Q1 202625,500$39.8K<0.1%+25,500NewHolders
Q1 20220$00.0%−10,688−100.0%Sold outHolders
Q4 202110,688$42.0K<0.1%−101,432−90.5%ReducedHolders
Q3 2021112,120$539.0K<0.1%−36,182−24.4%ReducedHolders
Q2 2021148,302$681.0K<0.1%−15,367−9.4%ReducedHolders
Q1 2021163,669$961.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.